A panel to discuss opportunities presented by smaller fusion companies pursuing original approaches and looking for Seed or series A funding:

• Why is it important to investigate less-mature approaches when other, established approaches are moving ahead at pace?
• Most fusion efforts focus on approaches that are capex-intensive but well researched over decades in public labs while simpler concepts are being pursued by other private companies. How do their risk profiles compare?
• What criteria do investors apply when researching and funding novel, early-stage fusion approaches?
• How can investments in alternative fusion approaches best fit in an investor’s portfolio?